Rhamnolipids enhance epithelial permeability in Caco-2 monolayers

International Journal of Pharmaceutics

Volumn 446, Issue 1-2, 2013, Pages 130-135

  Jiang, Lifang ^a   Long, Xuwei ^a   Meng, Qin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Absorption enhancer; P glycoprotein; Rhamnolipids; Transporter; Tween 80

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; PHENOLSULFONPHTHALEIN; POLYSORBATE 80; PROPRANOLOL; RHAMNOLIPID;

ABSORPTION; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION (PARAMETERS); DRUG TRANSPORT; EFFUSION; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE MUCOSA PERMEABILITY; MONOLAYER CULTURE; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; ERYTHROCYTES; FLUORESCENT DYES; GLYCOLIPIDS; HEMOLYSIS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; PERMEABILITY; RATS; RHODAMINE 123; RHODAMINES;

EID: 84874635180     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.003     Document Type: Article

References (49)

1. F.J. Aranda, and M.J. Espuny Thermodynamics of the interaction of a dirhamnolipid biosurfactant secreted by Pseudomonas aeruginosa with phospholipid membranes Langmuir 23 5 2007 2700 2705
2. A. Ardavanis, and D. Tryfonopoulos Non-allergic nature of docetaxel-induced acute hypersensitivity reactions Anticancer Drugs 15 6 2004 581 585
3. A.A. Badawi, and H.M. El-Laithy Optimization and evaluation of amoxicillin medium chain fatty acids/salts microemulsions: intestinal absorption and cytotoxicity J. Drug Deliv. Sci. Technol. 18 2 2008 109 118
4. E.V. Batrakova, and H.Y. Han Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers Pharm. Res. 15 6 1998 850 855
5. M. Benincasa, and A. Abalos Chemical structure, surface properties and biological activities of the biosurfactant produced by Pseudomonas aeruginosa LBI from soapstock Antonie Van Leeuwenhoek 85 1 2004 1 8
6. M.J. Cano-Cebrian, and T. Zornoza Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery Curr. Drug Deliv. 2 1 2005 9 22
7. Y.C. Chung, and Y.S. Kim Protein digestion and absorption in human small intestine Gastroenterology 76 6 1979 1415 1421
8. E.A. Coors, and H. Seybold Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions Ann. Allergy Asthma Immunol. 95 6 2005 593 599
9. A. Fasano, and S. Uzzau Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model J. Clin. Invest. 99 6 1997 1158 1164
10. Goran PILJAC et al., 1995. Immunological activity of rhamnolipids. United States 5466675.
11. E. Gundogdu, and V. Mangas-Sanjuan In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate Eur. J. Drug Metab. Pharmacokinet. 37 1 2012 65 75
12. S. Halldorsson, and T. Gudjonsson Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection Am. J. Respir. Cell Mol. Biol. 42 1 2010 62 68
13. U. Hanke, and K. May Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2) Eur. J. Pharm. Biopharm. 76 2 2010 260 268
14. M.E. Haque, and A.R. Das Mixed micelles of sodium deoxycholate and polyoxyethylene sorbitan monooleate (Tween 80) J. Colloid Interface Sci. 217 1 1999 1 7
15. Y. Ishigami Characterization of biosurfactants K. Esumi, M. Ueno, Structure-Performance Relationships in Surfactants 1997 Dekker New York 197 226
16. S.C. Jagdale, and A.J. Agavekar Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride AAPS PharmSciTech 10 3 2009 1071 1079
17. C.S. Karyekar, and A. Fasano Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells J. Pharm. Sci. 92 2 2003 414 423
18. M. Kondoh, and A. Takahashi Spiral progression in the development of absorption enhancers based on the biology of tight junctions Adv. Drug Deliv. Rev. 64 2 2012 515 522
19. S.A. Lewis Assessing epithelial cell confluence by spectroscopy Methods Mol. Biol. 188 2002 329 336
20. T. Lindmark, and J.D. Soderholm Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate Pharm. Res. 14 7 1997 930 935
21. C.A. Lipinski, and F. Lombardo Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 1-3 2001 3 26
22. S. Maher, and L. Feighery Melittin as an epithelial permeability enhancer I: Investigation of its mechanism of action in Caco-2 monolayers Pharm. Res. 24 7 2007 1336 1345
23. S. Maher, and D.J. Brayden Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs Crit. Rev. Ther. Drug Carrier Syst. 25 2 2008 117 168
24. S. Maher, and T.W. Leonard Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic Adv. Drug Deliv. Rev. 61 15 2009 1427 1449
25. J. Miyoshi, and Y. Takai Molecular perspective on tight-junction assembly and epithelial polarity Adv. Drug Deliv. Rev. 57 6 2005 815 855
26. S. Neuhoff, and A.L. Ungell pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions Pharm. Res. 20 8 2003 1141 1148
27. M. Nitschkea, and S.G.V.A.O. Costa Biosurfactants in food industry Trend Food Sci. Technol. 18 2007 252 259
28. A. Ortiz, and J.A. Teruel Effects of dirhamnolipid on the structural properties of phosphatidylcholine membranes Int. J. Pharm. 325 1-2 2006 99 107
29. A. Ortiz, and F.J. Aranda Interaction of dirhamnolipid biosurfactants with phospholipid membranes: a molecular level study Adv. Exp. Med. Biol. 672 2010 42 53
30. J.L. Parra, J. Guinea, and A. Manresa Chemical characterization and physicochemical behaviour of biosurfactants J. Am. Oil Chem. Soc. 66 1989 141 145
31. K.S. Price, and R.G. Hamilton Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy Allergy Asthma Proc. 28 3 2007 313 319
32. B.D. Rege, and L.X. Yu Effect of common excipients on Caco-2 transport of low-permeability drugs J. Pharm. Sci. 90 11 2001 1776 1786
33. B.D. Rege, and J.P. Kao Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 4-5 2002 237 246
34. M. Sanchez, and F.J. Aranda Permeabilization of biological and artificial membranes by a bacterial dirhamnolipid produced by Pseudomonas aeruginosa J. Colloid Interface Sci. 341 2 2010 240 247
35. G. Soberon-Chavez, and F. Lepine Production of rhamnolipids by Pseudomonas aeruginosa Appl. Microbiol. Biotechnol. 68 6 2005 718 725
36. T. Sugiyama, and A. Yamamoto Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment Biol. Pharm. Bull. 20 7 1997 812 814
37. E.S. Swenson, and W.B. Milisen Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility Pharm. Res. 11 8 1994 1132 1142
38. E.S. Swenson, and W.B. Milisen Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers Pharm. Res. 11 10 1994 1501 1504
39. Y. Takahashi, and H. Kondo Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs Int. J. Pharm. 246 1-2 2002 85 94
40. A.J. ten Tije, and J. Verweij Pharmacological effects of formulation vehicles: implications for cancer chemotherapy Clin. Pharmacokinet. 42 7 2003 665 685
41. J.R. Turner Intestinal mucosal barrier function in health and disease Nat. Rev. Immunol. 9 11 2009 799 809
42. T. Uchiyama, and T. Sugiyama Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-d- maltopyranoside J. Pharm. Pharmacol. 51 11 1999 1241 1250
43. K.A. Walters, and P.H. Dugard Non-ionic surfactants and gastric mucosal transport of paraquat J. Pharm. Pharmacol. 33 4 1981 207 213
44. H.Z. Wang, and C.H. Chang Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells J. Ocul. Pharmacol. Ther. 12 1 1996 35 43
45. L.M. Whang, and P.W. Liu Application of biosurfactants, rhamnolipid, and surfactin, for enhanced biodegradation of diesel-contaminated water and soil J. Hazard. Mater. 151 1 2008 155 163
46. K. Whitehead, and N. Karr Safe and effective permeation enhancers for oral drug delivery Pharm. Res. 25 8 2008 1782 1788
47. W.J. Xia, and H. Onyuksel Mechanistic studies on surfactant-induced membrane permeability enhancement Pharm. Res. 17 5 2000 612 618
48. S.J. Zhu, and R.Q. Huang Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450 Eur. J. Pharm. Sci. 37 5 2009 573 580
49. L. Zulianello, and C. Canard Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa Infect. Immun. 74 6 2006 3134 3147